FCF Margin % is calculated as Free Cash Flow divided by its Revenue. AnaptysBio's Free Cash Flow for the
three
months ended in Dec. 2023 was $-34.63 Mil. AnaptysBio's Revenue for the
three
months ended in Dec. 2023 was $9.01 Mil. Therefore, AnaptysBio's FCF Margin % for the quarter that ended in Dec. 2023 was -384.55%.
The historical rank and industry rank for AnaptysBio's FCF Margin % or its related term are showing as below:
ANAB'
s FCF Margin % Range Over the Past 10 Years
Min: -991.38 Med: -136.07 Max: 91.29
Current: -708.79
During the past 11 years, the highest FCF Margin % of AnaptysBio was 91.29%. The lowest was -991.38%. And the median was -136.07%.
ANAB's FCF Margin % is ranked worse than 71.28% of 1034
companies
in the Biotechnology industry
Industry Median: -148.935
vs ANAB: -708.79
AnaptysBio FCF Margin % Historical Data
The historical data trend for AnaptysBio's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of AnaptysBio's FCF Margin %
For the Biotechnology subindustry, AnaptysBio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AnaptysBio's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, AnaptysBio's FCF Margin % distribution charts can be found below:
* The bar in red indicates where AnaptysBio's FCF Margin % falls into.
AnaptysBio FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
AnaptysBio's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AnaptysBio FCF Margin % Related Terms
Thank you for viewing the detailed overview of AnaptysBio's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
AnaptysBio Inc is a clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonists. The entity generates revenue from collaborative research and development arrangements.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ANAB has been successfully added to your 